Tobiloba E. Oni
YOU?
Author Swipe
View article: Inflammation awakens dormant cancer cells by modulating the epithelial–mesenchymal phenotypic state
Inflammation awakens dormant cancer cells by modulating the epithelial–mesenchymal phenotypic state Open
The awakening of dormant disseminated cancer cells appears to be responsible for the clinical relapses of patients whose primary tumors have been successfully cured months and even years earlier. In the present study, we demonstrate that d…
View article: Supplementary Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Supplementary Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
Supplementary Figure legends
View article: Supplementary Table S1 from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Supplementary Table S1 from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
DNA motif analysis
View article: Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
Pancreatic ductal adenocarcinoma (PDAC) is poorly responsive to therapies and histologically contains a paucity of neoplastic cells embedded within a dense desmoplastic stroma. Within the stroma, cancer-associated fibroblasts (CAF) secrete…
View article: Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
Pancreatic ductal adenocarcinoma (PDAC) is poorly responsive to therapies and histologically contains a paucity of neoplastic cells embedded within a dense desmoplastic stroma. Within the stroma, cancer-associated fibroblasts (CAF) secrete…
View article: Supplementary Table S1 from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Supplementary Table S1 from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
DNA motif analysis
View article: Combined Supplementary Figures from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Combined Supplementary Figures from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
Supplementary Figures S1-S8
View article: Combined Supplementary Figures from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Combined Supplementary Figures from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
Supplementary Figures S1-S8
View article: Supplementary Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Supplementary Data from IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Open
Supplementary Figure legends
View article: Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer
Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer Open
Purpose:KRAS is mutated in the majority of pancreatic ductal adenocarcinoma. MAPK and PI3K-AKT are primary KRAS effector pathways, but combined MAPK and PI3K inhibition has not been demonstrated to be clinically effective to date. We explo…
View article: SFigure5 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure5 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure5
View article: Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer
Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer Open
Purpose:KRAS is mutated in the majority of pancreatic ductal adenocarcinoma. MAPK and PI3K-AKT are primary KRAS effector pathways, but combined MAPK and PI3K inhibition has not been demonstrated to be clinically effective to date. We explo…
View article: Supplementary Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Supplementary Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
Supp Figure legends
View article: Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
Purpose:Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease characterized by an extensive fibroinflammatory stroma, which includes abundant cancer-associated fibroblast (CAF) populations. PDAC CAFs are heterogeneous, but the nature…
View article: STable1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
STable1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
Table of antibodies.
View article: SFigure3 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure3 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure3
View article: SFigure4 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure4 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure4
View article: STable1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
STable1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
Table of antibodies.
View article: Supplementary Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer
Supplementary Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer Open
Supplementary Figures 1-3
View article: SFigure2 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure2 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure2
View article: SFigure1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure1
View article: SFigure2 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure2 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure2
View article: Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
Purpose:Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease characterized by an extensive fibroinflammatory stroma, which includes abundant cancer-associated fibroblast (CAF) populations. PDAC CAFs are heterogeneous, but the nature…
View article: Supplementary Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer
Supplementary Data from Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer Open
Supplementary Figures 1-3
View article: SFigure1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure1 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure1
View article: SFigure4 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure4 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure4
View article: SFigure5 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure5 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure5
View article: Supplementary Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Supplementary Data from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
Supp Figure legends
View article: SFigure3 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
SFigure3 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Open
SFigure3